![]() |
Swartz Research Group |
|||||||||||
381 North South Mall, Stanford, CA 94305-5025 650.736-1807 [Phone] 650.725-7294 [Fax] |
||||||||||||
| | Home | Prof. James Swartz | Publications | Associates | | ||||||||||||
|
James R. SwartzProfessor of Chemical Engineering and Bioengineering Leland T. Edwards Professor in the School of Engineering Member of the National Academy of Engineering (NAE) D. Sci. Massachusetts Institute of Technology
In the medical area, current research addresses the need for patient-specific vaccines to treat cancer. Particularly for lymphomas,there is a strong need to be able to make a new cancer vaccinefor each patient. Current technologies are slow andexpensive, but cell-free approaches are rapid and inexpensive. We have already Express GMCSFscTCR Fusion Diseased T- Cell Displaying Unique Receptor Recover DNA Encoding TCR Variable Region Immunize Patient’s Immune System Antibodies Attacking Diseased T Cells demonstrated feasibility in mouse tumor challenge studies and are now expanding the range of applications and working to improve the relevant technologies. Experience with these vaccines has also suggested a new and exciting format for making inexpensive and very potent vaccines for general use.
To address pressing needs for a new and cleaner energy source, we are working towards an organism that can efficiently capture solar energy and convert it into hydrogen. The first task is to develop an oxygen tolerant hydrogenase using cell-free technology to express libraries of mutated enzymes that can be rapidly screened for improved function. Even though these are very complex enzymes, we have produced active hydrogenases with our cellfree methods. We are now perfecting the screening methods for rapid and accurate identification of improved enzymes. After these new enzymes are identified, the project will progress toward metabolic engineering and bioreactor design research to achieve the scales and economies required. To address environmental needs, we are developing an improved water filters using an amazing membrane protein, Aquaporin Z. It has the ability to reject all other chemicals and ions except water. We have efficiently expressed the protein into lipid bilayer vesicles and are now working to cast these membranes on porous supports to complete the development of a new and powerful water purification technology. The same lessons will be applied toward the development of a new class of biosensors that brings high sensitivity and selectivity. |
In the NewsSwartz received Gaden Award at ACS Meeting (9/27/06) Professor James Swartz-Global Climate and Energy Project James Swartz and Nathan Lassig: Meeting of the minds: Student finds ideal setting for protein research
Featured Events at Stanford: EngineeringBio-X Interdisciplinary Initiatives Symposium - August 31, 2006 |
||||||||||
| | Copyright © 2006. Swartz Lab. All Rights Reserved | | ChemE Library | Stanford - NIH Biotechnology | CPIMA | Bio-X Program | | |||||||||||